Perfusion Systems Market to 2027- Global Analysis and Forecasts by Type ; Component and Geography
出 版 商：The Insight Partners
出版日期：2019/03/15
頁 數：167頁
文件格式：PDF
價 格：
USD 4,550 (Single-User License)
USD 6,550 (Multi-User License)
USD 8,550 (Global-User License)
USD 6,550 (Multi-User License)
USD 8,550 (Global-User License)
The global perfusion systems market is expected to reach US$ 1,442.28 Mn in 2027 from US$ 1,044.75 Mn in 2018. The market is estimated to grow with a CAGR of 3.8% from 2019-2027.
The growth of the perfusion systems market is primarily attributed to the rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation, and rising cell based research activities. However, expensive organ transplant surgeries, and limited numbers of donors for organ transplant surgeries are likely to pose a negative impact on the market growth. On the other hand, growth opportunities in emerging regions is likely to have a positive impact on the growth of the global perfusion systems market in the coming years. Cardiovascular diseases (CVDs) is the leading cause of death across the globe, it affects more people as compared to any other disease. Other than the lifestyle and habit older people are more prone to the cardiovascular diseases. The ageing population commonly show the structural and functional alteration of vessels accumulation through their life. Thus it increases the risk of developing cardiovascular diseases. The prevalence of the cardiovascular diseases is increasing across the world. The key factors that lead to the occurrence of cardiovascular diseases among the population. As per the American College of Cardiology, it is stated that CVD contributes nearly 800,000deaths in the US, which is approximately to one out every three deaths. The coronary heart disease (CHD) contributes to the majority of CVD deaths which is further followed by stroke and heart failure. Nearly over 90 million Americans get diagnosed with CVD. In addition, it is stated that at a global level cardiovascular diseases contributes around 31% of all deaths and is expected that the cost of the CVD will be approximately to US$ 1,044 billion by 2030.
In 2018, the perfusion systems with bioreactor segment held a largest market share of 44.3% of the perfusion systems market, by type. This segment is also expected to dominate the market in 2027 owing to the increasing production by the biopharmaceutical and pharmaceutical and its advantages including, high quality of product, product stability, scalability. Moreover, the microfluidic perfusion systems segment is anticipated to also witness the significant growth rate of 3.9% during the forecast period, 2019 to 2027 owing to provide application at point of care.
Global perfusion systems market, based on component was segmented into oxygenators, heart-lung machines, perfusion pumps, monitoring systems, cannulas, and others. The oxygenators segment is anticipated to grow at a CAGR of 4.4% during the forecast period. The increasing number of the cardiovascular surgeries, liver transplantation and kidney transplantation across the world is likely to contribute to the growth and dominance of the segment. The oxygenators segment is also expected to exhibit highest growth witnessing a robust CAGR over the forecast years.
Some of the major primary and secondary sources for perfusion systems included in the report are Australasian Board of Cardiovascular Perfusion, Board of Cardiovascular Perfusion India, China Food & Drug Administration, contract research organizations, Food and Drug Administration, New Mexico Asthma Control Program and among others.
The growth of the perfusion systems market is primarily attributed to the rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation, and rising cell based research activities. However, expensive organ transplant surgeries, and limited numbers of donors for organ transplant surgeries are likely to pose a negative impact on the market growth. On the other hand, growth opportunities in emerging regions is likely to have a positive impact on the growth of the global perfusion systems market in the coming years. Cardiovascular diseases (CVDs) is the leading cause of death across the globe, it affects more people as compared to any other disease. Other than the lifestyle and habit older people are more prone to the cardiovascular diseases. The ageing population commonly show the structural and functional alteration of vessels accumulation through their life. Thus it increases the risk of developing cardiovascular diseases. The prevalence of the cardiovascular diseases is increasing across the world. The key factors that lead to the occurrence of cardiovascular diseases among the population. As per the American College of Cardiology, it is stated that CVD contributes nearly 800,000deaths in the US, which is approximately to one out every three deaths. The coronary heart disease (CHD) contributes to the majority of CVD deaths which is further followed by stroke and heart failure. Nearly over 90 million Americans get diagnosed with CVD. In addition, it is stated that at a global level cardiovascular diseases contributes around 31% of all deaths and is expected that the cost of the CVD will be approximately to US$ 1,044 billion by 2030.
In 2018, the perfusion systems with bioreactor segment held a largest market share of 44.3% of the perfusion systems market, by type. This segment is also expected to dominate the market in 2027 owing to the increasing production by the biopharmaceutical and pharmaceutical and its advantages including, high quality of product, product stability, scalability. Moreover, the microfluidic perfusion systems segment is anticipated to also witness the significant growth rate of 3.9% during the forecast period, 2019 to 2027 owing to provide application at point of care.
Global perfusion systems market, based on component was segmented into oxygenators, heart-lung machines, perfusion pumps, monitoring systems, cannulas, and others. The oxygenators segment is anticipated to grow at a CAGR of 4.4% during the forecast period. The increasing number of the cardiovascular surgeries, liver transplantation and kidney transplantation across the world is likely to contribute to the growth and dominance of the segment. The oxygenators segment is also expected to exhibit highest growth witnessing a robust CAGR over the forecast years.
Some of the major primary and secondary sources for perfusion systems included in the report are Australasian Board of Cardiovascular Perfusion, Board of Cardiovascular Perfusion India, China Food & Drug Administration, contract research organizations, Food and Drug Administration, New Mexico Asthma Control Program and among others.
TABLE OF CONTENTS
1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Global Perfusion Systems Market - By Type
1.3.2 Global Perfusion Systems Market - By Component
1.3.3 Global Perfusion Systems Market - By Geography
2. GLOBAL PERFUSION SYSTEMS MARKET - KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research
4. GLOBAL PERFUSION SYSTEMS MARKET - MARKET LANDSCAPE
4.1 OVERVIEW
4.2 PEST ANALYSIS
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & South Africa- PEST Analysis
4.2.5 South and Central America - PEST Analysis
5. GLOBAL PERFUSION SYSTEMS MARKET - KEY MARKET DYNAMICS
5.1 KEY MARKET DRIVERS
5.1.1 Rising Prevalence of Cardiovascular Diseases
5.1.2 Significant Growth of Pharmaceutical and Biotechnology Industries
5.1.3 Rising Need for The Organ Transplantation
5.1.4 Rising Cell Based Research Activities
5.2 KEY MARKET CHALLENGES
5.2.1 Expensive Organ Transplant Surgeries
5.2.2 Limited Numbers of Donors for Organ Transplant Surgeries
5.3 KEY MARKET OPPORTUNITIES
5.3.1 Growth Opportunities in Emerging Regions
5.4 IMPACT ANALYSIS
6. PERFUSION SYSTEMS MARKET - GLOBAL ANALYSIS
6.1 GLOBAL PERFUSION SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS
6.2 GLOBAL PERFUSION SYSTEMS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
6.3 PERFORMANCE OF KEY PLAYERS
6.3.1 Getinge AB
6.3.2 Medtronic
6.4 EXPERT OPINIONS
7. GLOBAL PERFUSION SYSTEMS MARKET ANALYSIS- BY TYPE
7.1 OVERVIEW
7.2 GLOBAL PERFUSION SYSTEMS MARKET BY TYPE, 2018 & 2027 (%)
7.3 MICROFLUIDIC PERFUSION SYSTEMS MARKET
7.3.1 Overview
7.3.2 Global Microfluidic Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 SMALL-MAMMAL ORGAN PERFUSION SYSTEMS MARKET
7.4.1 Overview
7.4.2 Global Small-Mammal Organ Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 BIOREACTORS PERFUSION SYSTEMS MARKET
7.5.1 Overview
7.5.2 Global Bioreactors Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 GRAVITY OR PRESSURE-DRIVEN PERFUSION SYSTEMS MARKET
7.6.1 Overview
7.6.2 Global Gravity or Pressure-Driven Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8. GLOBAL PERFUSION SYSTEMS MARKET ANALYSIS- BY COMPONENT
8.1 OVERVIEW
8.2 GLOBAL PERFUSION SYSTEMS MARKET, BY COMPONENT 2018 & 2027 (%)
8.3 PERFUSION PUMPS MARKET
8.3.1 Overview
8.3.2 Global Perfusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 OXYGENATORS MARKET
8.4.1 Overview
8.4.2 Global Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 HEART LUNG MACHINE MARKET
8.5.1 Overview
8.5.2 Global Heart-Lung Machine Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 MONITORING SYSTEMS MARKET
8.6.1 Overview
8.6.2 Global Monitoring Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 CANNULAS MARKET
8.7.1 Overview
8.7.2 Global Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 OTHERS MARKET
8.8.1 Overview
8.8.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1 NORTH AMERICA PERFUSION SYSTEMS MARKET
9.1.1 Overview
9.1.2 North America Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.1.3 North America Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.1.4 North America Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.1.5 North America Perfusion Systems Market Revenue and Forecasts to 2027,
By Country (%)
9.1.6 US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7 US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 US Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.1.7.2 US Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.1.8 Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9 Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.9.2 Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.1.10 Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11 Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11.1 Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.11.2 Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2 EUROPE PERFUSION SYSTEMS MARKET
9.2.1 Overview
9.2.2 Europe Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.3 Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.4 Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2.5 Europe Perfusion Systems Market Revenue and Forecasts to 2027,
By Country (%)
9.2.6 Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7 Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.7.2 Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2.8 UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9 UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.1 UK Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.2.9.2 UK Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.2.10 France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.11 France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.11.1 France Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.11.2 France Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2.12 Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.13 Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.13.1 Spain Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.2.13.2 Spain Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.2.14 Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.15 Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.15.1 Italy Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.2.15.2 Italy Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.3 ASIA PACIFIC PERFUSION SYSTEMS MARKET
9.3.1 Overview
9.3.2 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.3.3 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.4 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.3.5 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027,
By Country (%)
9.3.6 China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7 China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.1 China Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.3.7.2 China Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.3.8 Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9 Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.1 Japan Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.3.9.2 Japan Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.3.10 India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.11 India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.11.1 India Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.3.11.2 India Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.3.12 Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.13 Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.13.1 Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.13.2 Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.3.14 South Korea Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.3.15 South Korea Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.3.15.1 South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.15.2 South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.4 MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET
9.4.1 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.2 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.3 Middle East & Africa Perfusion Systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.4.4 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
9.4.5 UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6 UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.1 UAE Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.4.6.2 UAE Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.4.7 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.4.8 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.4.8.1 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.8.2 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.4.9 South Africa Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.4.10 South Africa Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.4.10.1 South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.10.2 South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.5 SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET
9.5.1 Overview
9.5.2 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.3 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.4 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.5.5 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
9.5.6 Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7 Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7.1 Brazil Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.5.7.2 Brazil Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.5.8 Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.9 Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.9.1 Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.9.2 Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
10. PERFUSION SYSTEMS MARKET -INDUSTRY LANDSCAPE
10.1 OVERVIEW
10.2 GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET, 2015-2018
10.3 ORGANIC DEVELOPMENTS
10.3.1 Overview
10.4 ORGANIC GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET,
2016-2018
10.5 PRODUCT APPROVAL
10.5.1 Recent Product Approval by Players in the Perfusion Systems Market,
2015-2018
10.6 PRODUCT LAUNCH
10.6.1 Recent Product Launch by Players in the Perfusion Systems Market, 2015-2018
10.7 OTHERS
10.7.1 Others Organic Strategies Made by the Players in the Perfusion Systems Market, 2015-2018
10.8 INORGANIC DEVELOPMENTS
10.8.1 Overview
10.9 INORGANIC GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET,
2015-2018
10.10 ACQUISITION
10.10.1 Acquisition Made by the Players in the perfusion systems Market, 2015-2018
10.11 PARTNERSHIPS
10.11.1 Recent Partnership by Players in the Perfusion Systems Market, 2015-2018
10.12 COLLABORATION
10.12.1 Collaboration by Players in the Perfusion Systems Market, 2015-2018
10.13 AGREEMENT
10.13.1 Agreement Made by the Players in the Perfusion Systems Market, 2015-2018
11. PERFUSION SYSTEMS MARKET-KEY COMPANY PROFILES
11.1 EXISTING PLAYERS
11.1.1 REPLIGEN CORPORATION
11.1.1.1 Key Facts
11.1.1.2 Business Description
11.1.1.3 Financial Overview
11.1.1.4 Product Portfolio
11.1.1.5 SWOT Analysis
11.1.1.6 Key Developments
11.1.2 Merck KGaA
11.1.2.1 Key Facts
11.1.2.2 Business Description
11.1.2.3 Financial Overview
11.1.2.4 Product Portfolio
11.1.2.5 SWOT Analysis
11.1.2.6 Key Developments
11.1.3 ALA Scientific Instruments, Inc.
11.1.3.1 Key Facts
11.1.3.2 Business Description
11.1.3.3 Financial Overview
11.1.3.4 Product Portfolio
11.1.3.5 SWOT Analysis
11.1.3.6 Key Developments
11.1.4 XVIVO Perfusion
11.1.4.1 Key Facts
11.1.4.2 Business Description
11.1.4.3 Financial Information
11.1.4.4 Product Portfolio
11.1.4.5 SWOT Analysis
11.1.4.6 Key Developments
11.1.5 Medtronic
11.1.5.1 Key Facts
11.1.5.2 Business Description
11.1.5.3 Financial Information
11.1.5.4 Product Portfolio
11.1.5.5 SWOT Analysis
11.1.5.6 Key Developments
11.1.6 XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
11.1.6.1 Key Facts
11.1.6.2 Business Description
11.1.6.3 Financial Information
11.1.6.4 Product Portfolio
11.1.6.5 SWOT Analysis
11.1.6.6 Key Developments
11.1.7 TERUMO CORPORATION
11.1.7.1 Key Facts
11.1.7.2 Business Description
11.1.7.3 Financial Overview
11.1.7.4 Product Portfolio
11.1.7.5 SWOT Analysis
11.1.7.6 Key Developments
11.1.8 Getinge AB
11.1.8.1 Key Facts
11.1.8.2 Business Description
11.1.8.3 Financial Overview
11.1.8.4 Product Portfolio
11.1.8.5 SWOT Analysis
11.1.8.6 Key Developments
11.1.9 Harvard Bioscience
11.1.9.1 Key Facts
11.1.9.2 Business Description
11.1.9.3 Financial Overview
11.1.9.4 Product Portfolio
11.1.9.5 SWOT Analysis
11.1.9.6 Key Developments
11.1.10 OrganOx
11.1.10.1 Key Facts
11.1.10.2 Business Description
11.1.10.3 Financial Overview
11.1.10.4 Product Portfolio
11.1.10.5 SWOT Analysis
11.1.10.6 Key Developments
11.2 EMERGING PLAYERS
11.2.1 Sartorius AG
11.2.1.1 Key Facts
11.2.1.2 Business Description
11.2.1.3 Financial Overview
11.2.1.4 Product Portfolio
11.2.1.5 SWOT Analysis
11.2.1.6 Key Developments
11.2.2 RAND
11.2.2.1 Key Facts
11.2.2.2 Business Description
11.2.2.3 Financial Overview
11.2.2.4 Product Portfolio
11.2.2.5 SWOT Analysis
11.2.2.6 Key Developments
11.2.3 LivaNova PLC
11.2.3.1 Key Facts
11.2.3.2 Business Description
11.2.3.3 Financial Overview
11.2.3.4 Product Portfolio
11.2.3.5 SWOT Analysis
11.2.3.6 Key Developments
11.2.4 Sanisure (Sani-Tech West, Inc.)
11.2.4.1 Key Facts
11.2.4.2 Business Description
11.2.4.3 Financial Overview
11.2.4.4 Product Portfolio
11.2.4.5 SWOT Analysis
11.2.4.6 Key Developments
11.2.5 AutoMate Scientific, Inc.
11.2.5.1 Key Facts
11.2.5.2 Business Description
11.2.5.3 Financial Overview
11.2.5.4 Product Portfolio
11.2.5.5 SWOT Analysis
11.2.5.6 Key Developments
11.2.6 APD (Advanced Perfusion Diagnostics)
11.2.6.1 Key Facts
11.2.6.2 Business Description
11.2.6.3 Financial Overview
11.2.6.4 Product Portfolio
11.2.6.5 SWOT Analysis
11.2.6.6 Key Developments
11.2.7 Spectrum Medical
11.2.7.1 Key Facts
11.2.7.2 Business Description
11.2.7.3 Financial Overview
11.2.7.4 Product Portfolio
11.2.7.5 SWOT Analysis
11.2.7.6 Key Developments
11.2.8 Transonic Systems Inc.
11.2.8.1 Key Facts
11.2.8.2 Business Description
11.2.8.3 Financial Overview
11.2.8.4 Product Portfolio
11.2.8.5 SWOT Analysis
11.2.8.6 Key Developments
11.2.9 ISCHEMAVIEW, INC
11.2.9.1 Key Facts
11.2.9.2 Business Description
11.2.9.3 Financial Overview
11.2.9.4 Product Portfolio
11.2.9.5 SWOT Analysis
11.2.9.6 Key Developments
11.2.10 CESCO BIOENGINEERING CO., LTD.
11.2.10.1 Key Facts
11.2.10.2 Business Description
11.2.10.3 Financial Overview
11.2.10.4 Product Portfolio
11.2.10.5 SWOT Analysis
11.2.10.6 Key Developments
11.2.11 Jobst Technologies GmbH
11.2.11.1 Key Facts
11.2.11.2 Business Description
11.2.11.3 Financial Overview
11.2.11.4 Product Portfolio
11.2.11.5 SWOT Analysis
11.2.11.6 Key Developments
12. APPENDIX
12.1 ABOUT THE INSIGHT PARTNERS
12.2 GLOSSARY OF TERMS
LIST OF TABLES
TABLE 1. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 2. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 3. US PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 4. US PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 5. CANADA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 6. CANADA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 7. MEXICO PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 8. MEXICO PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 9. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 10. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 11. GERMANY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 12. GERMANY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 13. UK PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 14. UK PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 15. FRANCE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 16. FRANCE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 17. SPAIN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 18. SPAIN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 19. ITALY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 20. ITALY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 21. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 22. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 23. CHINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 24. CHINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 25. JAPAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 26. JAPAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 27. INDIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 28. INDIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 29. AUSTRALIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 30. AUSTRALIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 31. SOUTH KOREA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 32. SOUTH KOREA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 33. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 34. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 35. UAE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 36. UAE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 37. SAUDI ARABIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 38. SAUDI ARABIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 39. SOUTH AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 40. SOUTH AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 41. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 42. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 43. BRAZIL PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 44. BRAZIL PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 45. ARGENTINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 46. ARGENTINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 47. RECENT PRODUCT APPROVAL BY PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 48. RECENT PRODUCT LAUNCH BY PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 49. OTHERS ORGANIC STRATEGIES MADE BY THE PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 50. ACQUISITION MADE BY THE PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 51. RECENT PARTNERSHIP IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 52. COLLABORATION IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 53. AGREEMENT MADE BY THE PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 54. GLOSSARY OF TERMS, PERFUSION SYSTEMS MARKET
LIST OF FIGURES
FIGURE 1. PERFUSION SYSTEMS MARKET SEGMENTATION
FIGURE 2. PERFUSION SYSTEMS SEGMENTATION, BY REGION
FIGURE 3. ASIA PACIFIC PERFUSION SYSTEMS MARKET, REVENUE (US$ MN),
BY GEOGRAPHY 2018 & 2027
FIGURE 4. GLOBAL PERFUSION SYSTEMS MARKET BY TYPE, MARKET SHARE (%), 2018
FIGURE 5. GLOBAL PERFUSION SYSTEMS MARKET BY COMPONENT, MARKET SHARE (%), 2018
FIGURE 6. NORTH AMERICA PEST ANALYSIS
FIGURE 7. EUROPE PEST ANALYSIS
FIGURE 8. ASIA PACIFIC PEST ANALYSIS
FIGURE 9. MIDDLE EAST & SOUTH AFRICA PEST ANALYSIS
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS
FIGURE 11. PERFUSION SYSTEMS MARKET IMPACT ANALYSIS OF DRIVER AND CHALLENGES
FIGURE 12. GLOBAL PERFUSION SYSTEMS MARKET - REVENUE FORECASTS AND ANALYSIS -2018- 2027
FIGURE 13. GLOBAL PERFUSION SYSTEMS MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2018- 2027
FIGURE 14. GLOBAL PERFUSION SYSTEMS MARKET, BY TYPE 2018 & 2027 (%)
FIGURE 15. GLOBAL MICROFLUIDIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 16. GLOBAL SMALL-MAMMAL ORGAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. GLOBAL BIOREACTORS PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 18. GLOBAL GRAVITY OR PRESSURE-DRIVEN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. GLOBAL PERFUSION SYSTEMS MARKET, BY COMPONENT 2018 & 2027 (%)
FIGURE 20. GLOBAL PERFUSION PUMPS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 21. GLOBAL OXYGENATORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 22. GLOBAL HEART-LUNG MACHINE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 23. GLOBAL MONITORING SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 24. GLOBAL CANNULAS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 26. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE OVERVIEW,
BY COUNTRY (2017) (US $ MN)
FIGURE 27. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 28. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 29. US PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 30. CANADA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 31. MEXICO PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 32. EUROPE PERFUSION SYSTEMS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
FIGURE 33. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 34. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COUNTRY (%)
FIGURE 35. GERMANY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 36. UK PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 37. FRANCE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 38. SPAIN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 39. ITALY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 40. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
FIGURE 41. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 42. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 43. CHINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 44. JAPAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 45. INDIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 46. AUSTRALIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 47. SOUTH KOREA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 48. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE OVERVIEW,
BY COUNTRY (2017) (US $ MN)
FIGURE 49. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 50. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 51. UAE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 52. SAUDI ARABIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 53. SOUTH AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 54. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
FIGURE 55. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 56. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 57. BRAZIL PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 58. ARGENTINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 59. GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET, 2015-2018
FIGURE 60. ORGANIC GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET,
2016-2018
FIGURE 61. INORGANIC DEVELOPMENTS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Global Perfusion Systems Market - By Type
1.3.2 Global Perfusion Systems Market - By Component
1.3.3 Global Perfusion Systems Market - By Geography
2. GLOBAL PERFUSION SYSTEMS MARKET - KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research
4. GLOBAL PERFUSION SYSTEMS MARKET - MARKET LANDSCAPE
4.1 OVERVIEW
4.2 PEST ANALYSIS
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & South Africa- PEST Analysis
4.2.5 South and Central America - PEST Analysis
5. GLOBAL PERFUSION SYSTEMS MARKET - KEY MARKET DYNAMICS
5.1 KEY MARKET DRIVERS
5.1.1 Rising Prevalence of Cardiovascular Diseases
5.1.2 Significant Growth of Pharmaceutical and Biotechnology Industries
5.1.3 Rising Need for The Organ Transplantation
5.1.4 Rising Cell Based Research Activities
5.2 KEY MARKET CHALLENGES
5.2.1 Expensive Organ Transplant Surgeries
5.2.2 Limited Numbers of Donors for Organ Transplant Surgeries
5.3 KEY MARKET OPPORTUNITIES
5.3.1 Growth Opportunities in Emerging Regions
5.4 IMPACT ANALYSIS
6. PERFUSION SYSTEMS MARKET - GLOBAL ANALYSIS
6.1 GLOBAL PERFUSION SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS
6.2 GLOBAL PERFUSION SYSTEMS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
6.3 PERFORMANCE OF KEY PLAYERS
6.3.1 Getinge AB
6.3.2 Medtronic
6.4 EXPERT OPINIONS
7. GLOBAL PERFUSION SYSTEMS MARKET ANALYSIS- BY TYPE
7.1 OVERVIEW
7.2 GLOBAL PERFUSION SYSTEMS MARKET BY TYPE, 2018 & 2027 (%)
7.3 MICROFLUIDIC PERFUSION SYSTEMS MARKET
7.3.1 Overview
7.3.2 Global Microfluidic Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 SMALL-MAMMAL ORGAN PERFUSION SYSTEMS MARKET
7.4.1 Overview
7.4.2 Global Small-Mammal Organ Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 BIOREACTORS PERFUSION SYSTEMS MARKET
7.5.1 Overview
7.5.2 Global Bioreactors Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 GRAVITY OR PRESSURE-DRIVEN PERFUSION SYSTEMS MARKET
7.6.1 Overview
7.6.2 Global Gravity or Pressure-Driven Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8. GLOBAL PERFUSION SYSTEMS MARKET ANALYSIS- BY COMPONENT
8.1 OVERVIEW
8.2 GLOBAL PERFUSION SYSTEMS MARKET, BY COMPONENT 2018 & 2027 (%)
8.3 PERFUSION PUMPS MARKET
8.3.1 Overview
8.3.2 Global Perfusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 OXYGENATORS MARKET
8.4.1 Overview
8.4.2 Global Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 HEART LUNG MACHINE MARKET
8.5.1 Overview
8.5.2 Global Heart-Lung Machine Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 MONITORING SYSTEMS MARKET
8.6.1 Overview
8.6.2 Global Monitoring Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 CANNULAS MARKET
8.7.1 Overview
8.7.2 Global Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 OTHERS MARKET
8.8.1 Overview
8.8.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1 NORTH AMERICA PERFUSION SYSTEMS MARKET
9.1.1 Overview
9.1.2 North America Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.1.3 North America Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.1.4 North America Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.1.5 North America Perfusion Systems Market Revenue and Forecasts to 2027,
By Country (%)
9.1.6 US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7 US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 US Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.1.7.2 US Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.1.8 Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9 Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.9.2 Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.1.10 Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11 Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11.1 Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.11.2 Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2 EUROPE PERFUSION SYSTEMS MARKET
9.2.1 Overview
9.2.2 Europe Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.3 Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.4 Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2.5 Europe Perfusion Systems Market Revenue and Forecasts to 2027,
By Country (%)
9.2.6 Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7 Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.7.2 Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2.8 UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9 UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.1 UK Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.2.9.2 UK Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.2.10 France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.11 France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.11.1 France Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.11.2 France Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2.12 Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.13 Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.13.1 Spain Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.2.13.2 Spain Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.2.14 Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.15 Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.15.1 Italy Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.2.15.2 Italy Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.3 ASIA PACIFIC PERFUSION SYSTEMS MARKET
9.3.1 Overview
9.3.2 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.3.3 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.4 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.3.5 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027,
By Country (%)
9.3.6 China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7 China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.1 China Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.3.7.2 China Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.3.8 Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9 Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.1 Japan Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.3.9.2 Japan Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.3.10 India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.11 India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.11.1 India Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.3.11.2 India Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.3.12 Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.13 Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.13.1 Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.13.2 Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.3.14 South Korea Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.3.15 South Korea Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.3.15.1 South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.15.2 South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.4 MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET
9.4.1 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.2 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.3 Middle East & Africa Perfusion Systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.4.4 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
9.4.5 UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6 UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.1 UAE Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.4.6.2 UAE Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.4.7 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.4.8 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.4.8.1 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.8.2 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.4.9 South Africa Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.4.10 South Africa Perfusion Systems Market Revenue and Forecasts to 2027
(US$ Mn)
9.4.10.1 South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.10.2 South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.5 SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET
9.5.1 Overview
9.5.2 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.3 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.4 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.5.5 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
9.5.6 Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7 Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7.1 Brazil Perfusion Systems Market Revenue and Forecasts to 2027,
By Type (US$ Mn)
9.5.7.2 Brazil Perfusion Systems Market Revenue and Forecasts to 2027,
By Component (US$ Mn)
9.5.8 Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.9 Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.9.1 Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.9.2 Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
10. PERFUSION SYSTEMS MARKET -INDUSTRY LANDSCAPE
10.1 OVERVIEW
10.2 GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET, 2015-2018
10.3 ORGANIC DEVELOPMENTS
10.3.1 Overview
10.4 ORGANIC GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET,
2016-2018
10.5 PRODUCT APPROVAL
10.5.1 Recent Product Approval by Players in the Perfusion Systems Market,
2015-2018
10.6 PRODUCT LAUNCH
10.6.1 Recent Product Launch by Players in the Perfusion Systems Market, 2015-2018
10.7 OTHERS
10.7.1 Others Organic Strategies Made by the Players in the Perfusion Systems Market, 2015-2018
10.8 INORGANIC DEVELOPMENTS
10.8.1 Overview
10.9 INORGANIC GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET,
2015-2018
10.10 ACQUISITION
10.10.1 Acquisition Made by the Players in the perfusion systems Market, 2015-2018
10.11 PARTNERSHIPS
10.11.1 Recent Partnership by Players in the Perfusion Systems Market, 2015-2018
10.12 COLLABORATION
10.12.1 Collaboration by Players in the Perfusion Systems Market, 2015-2018
10.13 AGREEMENT
10.13.1 Agreement Made by the Players in the Perfusion Systems Market, 2015-2018
11. PERFUSION SYSTEMS MARKET-KEY COMPANY PROFILES
11.1 EXISTING PLAYERS
11.1.1 REPLIGEN CORPORATION
11.1.1.1 Key Facts
11.1.1.2 Business Description
11.1.1.3 Financial Overview
11.1.1.4 Product Portfolio
11.1.1.5 SWOT Analysis
11.1.1.6 Key Developments
11.1.2 Merck KGaA
11.1.2.1 Key Facts
11.1.2.2 Business Description
11.1.2.3 Financial Overview
11.1.2.4 Product Portfolio
11.1.2.5 SWOT Analysis
11.1.2.6 Key Developments
11.1.3 ALA Scientific Instruments, Inc.
11.1.3.1 Key Facts
11.1.3.2 Business Description
11.1.3.3 Financial Overview
11.1.3.4 Product Portfolio
11.1.3.5 SWOT Analysis
11.1.3.6 Key Developments
11.1.4 XVIVO Perfusion
11.1.4.1 Key Facts
11.1.4.2 Business Description
11.1.4.3 Financial Information
11.1.4.4 Product Portfolio
11.1.4.5 SWOT Analysis
11.1.4.6 Key Developments
11.1.5 Medtronic
11.1.5.1 Key Facts
11.1.5.2 Business Description
11.1.5.3 Financial Information
11.1.5.4 Product Portfolio
11.1.5.5 SWOT Analysis
11.1.5.6 Key Developments
11.1.6 XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
11.1.6.1 Key Facts
11.1.6.2 Business Description
11.1.6.3 Financial Information
11.1.6.4 Product Portfolio
11.1.6.5 SWOT Analysis
11.1.6.6 Key Developments
11.1.7 TERUMO CORPORATION
11.1.7.1 Key Facts
11.1.7.2 Business Description
11.1.7.3 Financial Overview
11.1.7.4 Product Portfolio
11.1.7.5 SWOT Analysis
11.1.7.6 Key Developments
11.1.8 Getinge AB
11.1.8.1 Key Facts
11.1.8.2 Business Description
11.1.8.3 Financial Overview
11.1.8.4 Product Portfolio
11.1.8.5 SWOT Analysis
11.1.8.6 Key Developments
11.1.9 Harvard Bioscience
11.1.9.1 Key Facts
11.1.9.2 Business Description
11.1.9.3 Financial Overview
11.1.9.4 Product Portfolio
11.1.9.5 SWOT Analysis
11.1.9.6 Key Developments
11.1.10 OrganOx
11.1.10.1 Key Facts
11.1.10.2 Business Description
11.1.10.3 Financial Overview
11.1.10.4 Product Portfolio
11.1.10.5 SWOT Analysis
11.1.10.6 Key Developments
11.2 EMERGING PLAYERS
11.2.1 Sartorius AG
11.2.1.1 Key Facts
11.2.1.2 Business Description
11.2.1.3 Financial Overview
11.2.1.4 Product Portfolio
11.2.1.5 SWOT Analysis
11.2.1.6 Key Developments
11.2.2 RAND
11.2.2.1 Key Facts
11.2.2.2 Business Description
11.2.2.3 Financial Overview
11.2.2.4 Product Portfolio
11.2.2.5 SWOT Analysis
11.2.2.6 Key Developments
11.2.3 LivaNova PLC
11.2.3.1 Key Facts
11.2.3.2 Business Description
11.2.3.3 Financial Overview
11.2.3.4 Product Portfolio
11.2.3.5 SWOT Analysis
11.2.3.6 Key Developments
11.2.4 Sanisure (Sani-Tech West, Inc.)
11.2.4.1 Key Facts
11.2.4.2 Business Description
11.2.4.3 Financial Overview
11.2.4.4 Product Portfolio
11.2.4.5 SWOT Analysis
11.2.4.6 Key Developments
11.2.5 AutoMate Scientific, Inc.
11.2.5.1 Key Facts
11.2.5.2 Business Description
11.2.5.3 Financial Overview
11.2.5.4 Product Portfolio
11.2.5.5 SWOT Analysis
11.2.5.6 Key Developments
11.2.6 APD (Advanced Perfusion Diagnostics)
11.2.6.1 Key Facts
11.2.6.2 Business Description
11.2.6.3 Financial Overview
11.2.6.4 Product Portfolio
11.2.6.5 SWOT Analysis
11.2.6.6 Key Developments
11.2.7 Spectrum Medical
11.2.7.1 Key Facts
11.2.7.2 Business Description
11.2.7.3 Financial Overview
11.2.7.4 Product Portfolio
11.2.7.5 SWOT Analysis
11.2.7.6 Key Developments
11.2.8 Transonic Systems Inc.
11.2.8.1 Key Facts
11.2.8.2 Business Description
11.2.8.3 Financial Overview
11.2.8.4 Product Portfolio
11.2.8.5 SWOT Analysis
11.2.8.6 Key Developments
11.2.9 ISCHEMAVIEW, INC
11.2.9.1 Key Facts
11.2.9.2 Business Description
11.2.9.3 Financial Overview
11.2.9.4 Product Portfolio
11.2.9.5 SWOT Analysis
11.2.9.6 Key Developments
11.2.10 CESCO BIOENGINEERING CO., LTD.
11.2.10.1 Key Facts
11.2.10.2 Business Description
11.2.10.3 Financial Overview
11.2.10.4 Product Portfolio
11.2.10.5 SWOT Analysis
11.2.10.6 Key Developments
11.2.11 Jobst Technologies GmbH
11.2.11.1 Key Facts
11.2.11.2 Business Description
11.2.11.3 Financial Overview
11.2.11.4 Product Portfolio
11.2.11.5 SWOT Analysis
11.2.11.6 Key Developments
12. APPENDIX
12.1 ABOUT THE INSIGHT PARTNERS
12.2 GLOSSARY OF TERMS
LIST OF TABLES
TABLE 1. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 2. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 3. US PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 4. US PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 5. CANADA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 6. CANADA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 7. MEXICO PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 8. MEXICO PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 9. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 10. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 11. GERMANY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 12. GERMANY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 13. UK PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 14. UK PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 15. FRANCE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 16. FRANCE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 17. SPAIN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 18. SPAIN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 19. ITALY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 20. ITALY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 21. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 22. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 23. CHINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 24. CHINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 25. JAPAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 26. JAPAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 27. INDIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 28. INDIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 29. AUSTRALIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 30. AUSTRALIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 31. SOUTH KOREA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 32. SOUTH KOREA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 33. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 34. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 35. UAE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 36. UAE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 37. SAUDI ARABIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 38. SAUDI ARABIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 39. SOUTH AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 40. SOUTH AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 41. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 42. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 43. BRAZIL PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY TYPE (US$ MN)
TABLE 44. BRAZIL PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COMPONENT (US$ MN)
TABLE 45. ARGENTINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 46. ARGENTINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
TABLE 47. RECENT PRODUCT APPROVAL BY PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 48. RECENT PRODUCT LAUNCH BY PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 49. OTHERS ORGANIC STRATEGIES MADE BY THE PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 50. ACQUISITION MADE BY THE PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 51. RECENT PARTNERSHIP IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 52. COLLABORATION IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 53. AGREEMENT MADE BY THE PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
TABLE 54. GLOSSARY OF TERMS, PERFUSION SYSTEMS MARKET
LIST OF FIGURES
FIGURE 1. PERFUSION SYSTEMS MARKET SEGMENTATION
FIGURE 2. PERFUSION SYSTEMS SEGMENTATION, BY REGION
FIGURE 3. ASIA PACIFIC PERFUSION SYSTEMS MARKET, REVENUE (US$ MN),
BY GEOGRAPHY 2018 & 2027
FIGURE 4. GLOBAL PERFUSION SYSTEMS MARKET BY TYPE, MARKET SHARE (%), 2018
FIGURE 5. GLOBAL PERFUSION SYSTEMS MARKET BY COMPONENT, MARKET SHARE (%), 2018
FIGURE 6. NORTH AMERICA PEST ANALYSIS
FIGURE 7. EUROPE PEST ANALYSIS
FIGURE 8. ASIA PACIFIC PEST ANALYSIS
FIGURE 9. MIDDLE EAST & SOUTH AFRICA PEST ANALYSIS
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS
FIGURE 11. PERFUSION SYSTEMS MARKET IMPACT ANALYSIS OF DRIVER AND CHALLENGES
FIGURE 12. GLOBAL PERFUSION SYSTEMS MARKET - REVENUE FORECASTS AND ANALYSIS -2018- 2027
FIGURE 13. GLOBAL PERFUSION SYSTEMS MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2018- 2027
FIGURE 14. GLOBAL PERFUSION SYSTEMS MARKET, BY TYPE 2018 & 2027 (%)
FIGURE 15. GLOBAL MICROFLUIDIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 16. GLOBAL SMALL-MAMMAL ORGAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. GLOBAL BIOREACTORS PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 18. GLOBAL GRAVITY OR PRESSURE-DRIVEN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. GLOBAL PERFUSION SYSTEMS MARKET, BY COMPONENT 2018 & 2027 (%)
FIGURE 20. GLOBAL PERFUSION PUMPS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 21. GLOBAL OXYGENATORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 22. GLOBAL HEART-LUNG MACHINE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 23. GLOBAL MONITORING SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 24. GLOBAL CANNULAS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 26. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE OVERVIEW,
BY COUNTRY (2017) (US $ MN)
FIGURE 27. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 28. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 29. US PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 30. CANADA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 31. MEXICO PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 32. EUROPE PERFUSION SYSTEMS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
FIGURE 33. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 34. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027,
BY COUNTRY (%)
FIGURE 35. GERMANY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 36. UK PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 37. FRANCE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 38. SPAIN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 39. ITALY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 40. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
FIGURE 41. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 42. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 43. CHINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 44. JAPAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 45. INDIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 46. AUSTRALIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 47. SOUTH KOREA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 48. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE OVERVIEW,
BY COUNTRY (2017) (US $ MN)
FIGURE 49. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 50. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 51. UAE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 52. SAUDI ARABIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 53. SOUTH AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 54. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
FIGURE 55. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 56. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 57. BRAZIL PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027
(US$ MN)
FIGURE 58. ARGENTINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 59. GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET, 2015-2018
FIGURE 60. ORGANIC GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET,
2016-2018
FIGURE 61. INORGANIC DEVELOPMENTS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
